These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37493872)

  • 1. Radiomics predictive modeling from dual-time-point FDG PET K
    Samimi R; Shiri I; Ahmadyar Y; van den Hoff J; Kamali-Asl A; Rezaee A; Yousefirizi F; Geramifar P; Rahmim A
    EJNMMI Res; 2023 Jul; 13(1):70. PubMed ID: 37493872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images.
    Shiri I; Amini M; Nazari M; Hajianfar G; Haddadi Avval A; Abdollahi H; Oveisi M; Arabi H; Rahmim A; Zaidi H
    Comput Biol Med; 2022 Mar; 142():105230. PubMed ID: 35051856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomics analysis for the differentiation of autoimmune pancreatitis and pancreatic ductal adenocarcinoma in
    Zhang Y; Cheng C; Liu Z; Wang L; Pan G; Sun G; Chang Y; Zuo C; Yang X
    Med Phys; 2019 Oct; 46(10):4520-4530. PubMed ID: 31348535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding the temporal domain to PET radiomic features.
    Noortman WA; Vriens D; Slump CH; Bussink J; Meijer TWH; de Geus-Oei LF; van Velden FHP
    PLoS One; 2020; 15(9):e0239438. PubMed ID: 32966313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dual time point protocols to produce parametric K
    Reshtebar N; Hosseini SA; Zhuang M; Rahmim A; Karakatsanis NA; Sheikhzadeh P
    Med Phys; 2024 Dec; 51(12):9088-9102. PubMed ID: 39341228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Parametric MRI-Based Radiomics Models for Predicting Molecular Subtype and Androgen Receptor Expression in Breast Cancer.
    Huang Y; Wei L; Hu Y; Shao N; Lin Y; He S; Shi H; Zhang X; Lin Y
    Front Oncol; 2021; 11():706733. PubMed ID: 34490107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine learning-based prognostic modeling using clinical data and quantitative radiomic features from chest CT images in COVID-19 patients.
    Shiri I; Sorouri M; Geramifar P; Nazari M; Abdollahi M; Salimi Y; Khosravi B; Askari D; Aghaghazvini L; Hajianfar G; Kasaeian A; Abdollahi H; Arabi H; Rahmim A; Radmard AR; Zaidi H
    Comput Biol Med; 2021 May; 132():104304. PubMed ID: 33691201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical harmonization can improve the development of a multicenter CT-based radiomic model predictive of nonresponse to induction chemotherapy in laryngeal cancers.
    Masson I; Da-Ano R; Lucia F; Doré M; Castelli J; Goislard de Monsabert C; Ramée JF; Sellami S; Visvikis D; Hatt M; Schick U
    Med Phys; 2021 Jul; 48(7):4099-4109. PubMed ID: 34008178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT radiomics analysis of lung cancers: Differentiation of squamous cell carcinoma from adenocarcinoma, a correlative study with FDG uptake.
    Tomori Y; Yamashiro T; Tomita H; Tsubakimoto M; Ishigami K; Atsumi E; Murayama S
    Eur J Radiol; 2020 Jul; 128():109032. PubMed ID: 32361604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics signature from [
    Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
    Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow segmentation and radiomics analysis of [
    Milara E; Gómez-Grande A; Tomás-Soler S; Seiffert AP; Alonso R; Gómez EJ; Martínez-López J; Sánchez-González P
    Comput Methods Programs Biomed; 2022 Oct; 225():107083. PubMed ID: 36044803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer.
    Zhang H; Niu S; Chen H; Wang L; Wang X; Wu Y; Shi J; Li Z; Hu Y; Yang Z; Jiang X
    Front Cell Dev Biol; 2023; 11():1220320. PubMed ID: 38264355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual time-point [
    Samimi R; Kamali-Asl A; Ahmadyar Y; van den Hoff J; Geramifar P; Rahmim A
    Phys Med; 2024 May; 121():103336. PubMed ID: 38626637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
    Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
    Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidomain fusion model of radiomics and deep learning to discriminate between PDAC and AIP based on
    Wei W; Jia G; Wu Z; Wang T; Wang H; Wei K; Cheng C; Liu Z; Zuo C
    Jpn J Radiol; 2023 Apr; 41(4):417-427. PubMed ID: 36409398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Cross-Combinations of Feature Selection and Machine-Learning Classification Methods Based on [
    Gómez OV; Herraiz JL; Udías JM; Haug A; Papp L; Cioni D; Neri E
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
    Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
    Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.
    Eertink JJ; Zwezerijnen GJC; Cysouw MCF; Wiegers SE; Pfaehler EAG; Lugtenburg PJ; van der Holt B; Hoekstra OS; de Vet HCW; Zijlstra JM; Boellaard R
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4642-4651. PubMed ID: 35925442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.